首页> 美国卫生研究院文献>other >BRCA1 promoter deletions in young women with breast cancer and a strong family history: a population based study.
【2h】

BRCA1 promoter deletions in young women with breast cancer and a strong family history: a population based study.

机译:乳腺癌且有悠久家族史的年轻女性中BRCA1启动子的缺失:一项基于人群的研究。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Women diagnosed with breast cancer before the age of 40 years who have a strong family history of breast and/or ovarian cancer were selected from an Australian population-based case-control-family study for large deletion screening within the BRCA1 promoter. Deletions within the BRCA1 promoter region are usually not detected by the methods applied in routine clinical mutation detection strategies. Fifty-one of the 66 women (77%) who met our inclusion criteria were tested for promoter deletions using linkage disequilibrium analysis of two BRCA1 polymorphic sites (C/G1802 and Pro871Leu) and Multiplex Ligation-dependent Probe Amplification. Two cases of BRCA1 promoter deletion involving exons 1A-2, and exons 1A-23, were detected. The morphology of the breast cancers arising in these women with BRCA1 promoter deletions was consistent with the morphology associated with other germline BRCA1 mutations. Large genomic deletions that involve the promoter regions of BRCA1 make up 20% (2/10) of all known BRCA1 mutations in this group of young women with a strong family history of breast and ovarian cancer. Our data supports the inclusion of testing for large genomic alterations in the BRCA1 promoter region in routine clinical mutation detection within BRCA1.
机译:从澳大利亚人口为基础的病例对照家庭研究中,从40岁以下被诊断患有乳腺癌的女性中,他们具有很强的乳腺癌和/或卵巢癌家族史,这些患者被选用于BRCA1启动子中的大缺失筛选。 BRCA1启动子区域内的缺失通常无法通过常规临床突变检测策略中应用的方法检测到。使用两个BRCA1多态性位点(C / G1802和Pro871Leu)的连锁不平衡分析和多重连接依赖性探针扩增,对符合我们纳入标准的66名女性中的51名(77%)进行了启动子缺失测试。发现了2个涉及外显子1A-2和外显子1A-23的BRCA1启动子缺失的情况。这些患有BRCA1启动子缺失的妇女的乳腺癌形态与其他种系BRCA1突变相关的形态一致。在具有乳腺癌和卵巢癌家族史的年轻女性中,涉及BRCA1启动子区域的大基因组缺失占所有已知BRCA1突变的20%(2/10)。我们的数据支持在BRCA1内进行常规临床突变检测中包括对BRCA1启动子区域中大基因组改变的测试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号